Connect
MJA
MJA

Latrodectism: a prospective cohort study of bites by formally identified redback spiders

Geoffrey K Isbister and Michael R Gray
Med J Aust 2003; 179 (2): 88-91.

Summary

Objective: To determine the spectrum of severity and early diagnostic predictors of redback spider bites (Latrodectus hasselti ), and to examine the effect of intramuscular redback antivenom.

Design and setting: Prospective cohort study of calls to New South Wales, Queensland and Western Australian poisons information centres and presentations to Royal Prince Alfred Hospital and Royal Darwin Hospital emergency departments.

Patients: 68 people with definite redback spider bites in which the spider was immediately collected and expertly identified (1 February 1999 to 30 April 2002).

Interventions: Intramuscular redback spider antivenom in a smaller cohort of hospitalised patients.

Main outcome measures: Pain severity and duration, local effects and systemic envenomation (effects, prevalence, and persistence > 24 hours).

Results: The median duration of effects was 48 hours (interquartile range, 24–96 hours). Pain occurred after all bites and was severe in 42 (62%). Forty-five patients (66%) had pain lasting longer than 24 hours, and 22 (32%) were unable to sleep because of pain. Systemic effects occurred in 24 (35%). Increasing pain over one hour occurred in 37 cases (54%), and local/regional diaphoresis in 23 (34%); both these features were highly predictive of L. hasselti bites compared with bites of other spiders. One of six patients treated with intramuscular antivenom (17%) had no pain at 24 hours, compared with two of 17 untreated patients (12%) (difference, 5%; 95% CI, –36% to +64%; P = 0.95). There was no difference in duration of systemic effects with antivenom administration.

Conclusions: Most redback spider bites cause severe and persistent effects. Intramuscular antivenom appears to be less effective than previously thought and its use by this route needs review.

Please login with your free MJA account to view this article in full

  • Geoffrey K Isbister1
  • Michael R Gray2

  • 1 Discipline of Clinical Pharmacology, University of Newcastle, Waratah, NSW.
  • 2 Division of Invertebrate Zoology, Australian Museum, Sydney, NSW.

Correspondence: 

Acknowledgements: 

We would like to acknowledge the large number of people who have made this study possible, including the poison information specialists from the NSW, WA and QLD poison information centres, and the nursing staff and doctors in many emergency departments around Australia who have assisted in recruiting cases via the poisons information centres. Particular thanks to a number of clinicians who have made it possible to organise the study or given advice regarding the design of the study, including Bart Currie. Thanks to David Henry, Ian Whyte, Nick Buckley, Bart Currie and Patricia McGettigan for comments on the methodology and David Sibbritt for review of the statistical analysis. Thanks to Tony Smith for commenting on the manuscript.

Competing interests:

None identified.

  • 1. Bettini S, Maroli M. Venoms of Theridiidae, Genus Latrodectus. In: Bettini S, editor. Arthropod venoms. Berlin: Springer-Verlag, 1978; 149-189.
  • 2. Stallybrass FC. Spider bites. Lancet 1969; 1: 572.
  • 3. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med 1992; 21: 782-787.
  • 4. Isbister GK, Gray MR. A prospective study of 750 definite spider bites, with expert spider identification. QJM 2002; 95: 723-731.
  • 5. Vetter RS, Visscher PK. Bites and stings of medically important venomous arthropods. Int J Dermatol 1998; 37: 481-496.
  • 6. Isbister GK. Failure of intramuscular antivenom in redback spider envenomation. Emerg Med (Fremantle) 2002; 14: 436-439.
  • 7. Nicholson GM, Graudins A. Spiders of medical importance in the Asia-Pacific: atracotoxin, latrotoxin and related spider neurotoxins. Clin Exp Pharmacol Physiol 2002; 29: 785-794.
  • 8. White J. Envenoming and antivenom use in Australia. Toxicon 1998; 36: 1483-1492.
  • 9. White J, Cardoso JL, Hui WF. Clinical toxicology of spider bites. In: Meier J, White J, editors. Handbook of clinical toxicology of animal venoms and poisons. Boca Raton, Fl: CRC Press, 1995; 259-330.
  • 10. Jelinek GA, Banham NG, Dunjey SJ. Red-back spider-bites at Fremantle Hospital, 1982–1987. Med J Aust 1989; 150: 693-695.
  • 11. White J. CSL antivenom handbook. 2nd edn. Melbourne: CSL Ltd, 2001.
  • 12. Wiener S. Redback spider bite in Australia: an analysis of 167 cases. Med J Aust 1961; 2: 44-49.
  • 13. Isbister GK, Gray MR. White-tail spider bite: a prospective study of 130 definite bites by Lampona species. Med J Aust 2003; in press.
  • 14. GraphPad StatMate [computer program]. Version 1.0. San Diego: GraphPad Software, Inc, 1995.
  • 15. GraphPad InStat [computer program]. Version 3.05 San Diego: GraphPad Software, Inc, 2000.
  • 16. StatXact [computer program]. Version 4.0. Cambridge, Mass: Cytel Software Corporation, 1998.
  • 17. Mead HJ, Jelinek GA. Red-back spider bites to Perth children, 1979–1988. J Paediatr Child Health 1993; 29: 305-308.
  • 18. Fisher MM, Bowey CJ. Urban envenomation. Med J Aust 1989; 150: 695-698.
  • 19. Sutherland SK, Trinca JC. Survey of 2144 cases of red-back spider bites: Australia and New Zealand, 1963–1976. Med J Aust 1978; 2: 620-623.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.